IL156104A0 - Process for preparing non-hygroscopic sodium valproate composition - Google Patents

Process for preparing non-hygroscopic sodium valproate composition

Info

Publication number
IL156104A0
IL156104A0 IL15610402A IL15610402A IL156104A0 IL 156104 A0 IL156104 A0 IL 156104A0 IL 15610402 A IL15610402 A IL 15610402A IL 15610402 A IL15610402 A IL 15610402A IL 156104 A0 IL156104 A0 IL 156104A0
Authority
IL
Israel
Prior art keywords
sodium valproate
preparing non
hygroscopic sodium
composition
valproate composition
Prior art date
Application number
IL15610402A
Other languages
English (en)
Original Assignee
Taro Pharma Ind
Taro Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taro Pharma Ind, Taro Pharmaceuticals Ltd filed Critical Taro Pharma Ind
Publication of IL156104A0 publication Critical patent/IL156104A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15610402A 2001-01-24 2002-01-24 Process for preparing non-hygroscopic sodium valproate composition IL156104A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/767,853 US20020143058A1 (en) 2001-01-24 2001-01-24 Process for preparing non-hygroscopic sodium valproate composition
PCT/US2002/002076 WO2002058666A2 (en) 2001-01-24 2002-01-24 Process for preparing non-hygroscopic sodium valproate composition

Publications (1)

Publication Number Publication Date
IL156104A0 true IL156104A0 (en) 2003-12-23

Family

ID=25080780

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15610402A IL156104A0 (en) 2001-01-24 2002-01-24 Process for preparing non-hygroscopic sodium valproate composition

Country Status (10)

Country Link
US (3) US20020143058A1 (es)
EP (1) EP1353650A2 (es)
JP (1) JP2004521890A (es)
CN (1) CN1487827A (es)
BR (1) BR0206730A (es)
CA (1) CA2434226A1 (es)
IL (1) IL156104A0 (es)
MX (1) MXPA03006625A (es)
RU (1) RU2003126177A (es)
WO (1) WO2002058666A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003240164A1 (en) * 2002-06-07 2003-12-22 Ranbaxy Laboratories Limited Extended release formulation of divalproex sodium
US20040005357A1 (en) * 2002-07-03 2004-01-08 Sherman Bernard Charles Extended-release tablets comprising divalproex sodium
US20040091581A1 (en) * 2002-11-08 2004-05-13 Ghislaine Joly Starch/collagen casings for co-extruded food products
ATE353633T1 (de) * 2002-12-19 2007-03-15 Pharmacia Corp Nicht-hygroskopische formulierung, die einen hygroskopischen wirkstoff enthält
EP1837020A1 (en) 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
PL204780B1 (pl) * 2006-06-02 2010-02-26 Zak & Lstrok Ady Farmaceutyczn Tabletka powlekana o przedłużonym uwalnianiu substancji aktywnej otrzymywana metodą bezpośredniego tabletkowania zawierająca indapamid albo jego farmaceutyczną sól oraz farmaceutycznie dopuszczalne wypełniacze, zastosowanie karbomeru do wytwarzania tabletki oraz sposób jej powlekania
WO2008033740A2 (en) * 2006-09-11 2008-03-20 Hydrogen Discoveries Inc. Mitigating hydrogen flux through solid and liquid barrier materials
MX2009005921A (es) 2006-12-13 2009-06-17 Hoffmann La Roche Formulacion en polvo del valganciclovir.
WO2008102264A2 (en) * 2007-02-20 2008-08-28 Eurand Pharmaceuticals Limited Stable digestive enzyme compositions
US20100122747A1 (en) * 2007-09-10 2010-05-20 Hydrogen Discoveries, Inc. Composite Structures for Hydrogen Storage and Transfer
US20100204325A1 (en) * 2009-02-11 2010-08-12 Allergan, Inc. Valproic acid drug delivery systems and intraocular therapeutic uses thereof
SI2412369T1 (sl) * 2009-03-27 2016-12-30 Torray Industries, Inc. Obloženi trdni pripravek
CN110448536A (zh) * 2019-08-23 2019-11-15 仁和堂药业有限公司 丙戊酸钠片剂及其加工工艺
CN113304117B (zh) * 2021-04-30 2023-05-12 山东京卫制药有限公司 一种丙戊酸钠缓释片的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212326A (en) 1979-08-20 1993-05-18 Abbott Laboratories Sodium hydrogen divalproate oligomer
US4988731A (en) 1979-08-20 1991-01-29 Abbott Laboratories Sodium hydrogen divalproate oligomer
US4301176A (en) 1980-08-18 1981-11-17 Warner-Lambert Company Method of administering calcium valproate
US5185159A (en) * 1983-07-20 1993-02-09 Sanofi Pharmaceutical composition based on valproic acid and a process for preparing it
IL72381A (en) 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid
US4913906B1 (en) * 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
US4772540A (en) 1985-08-30 1988-09-20 Bar Ilan University Manufacture of microsieves and the resulting microsieves
ATE68346T1 (de) 1987-07-22 1991-11-15 Farvalsa Ag Feuchtigkeitsstabile feste valproinsaeurezubereitung und verfahren zu ihrer herstellung.
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
PT571973E (pt) 1992-05-29 2000-05-31 Nikken Chemicals Co Ltd Comprimidos de valproato de sodio de libertacao retardada
US6287598B1 (en) 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy

Also Published As

Publication number Publication date
US20020143058A1 (en) 2002-10-03
CA2434226A1 (en) 2002-08-01
WO2002058666A2 (en) 2002-08-01
BR0206730A (pt) 2004-02-10
MXPA03006625A (es) 2004-11-12
US20040208927A1 (en) 2004-10-21
CN1487827A (zh) 2004-04-07
US20030119872A1 (en) 2003-06-26
JP2004521890A (ja) 2004-07-22
RU2003126177A (ru) 2005-01-10
US6752997B2 (en) 2004-06-22
EP1353650A2 (en) 2003-10-22
WO2002058666A3 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
HUP0200402A3 (en) An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine
HUP0302060A3 (en) Method for preparing compositions
EP1447440A4 (en) CLEANING SUPPLIES
IL156104A0 (en) Process for preparing non-hygroscopic sodium valproate composition
IL151691A0 (en) Novel process for preparing (+)-cis-sertraline
HK1039796A1 (zh) 生產過硫酸鈉的方法
HU0104405D0 (en) Process for preparing imidachlopid
IL156145A0 (en) Process for the preparation of phenethylamine derivatives
AU5219001A (en) Process for preparing fluid detergent compositions
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
IL150043A0 (en) Method for preparing bromodifluoroacetic compounds
HUP0303102A3 (en) Process for producing substituted aniline compound
HUP0400080A3 (en) Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate
HUP0302313A3 (en) Co-retarding agents for preparing purified brine
HRP20031052A2 (en) Process for the preparation of amorphous cilastatin sodium
GB0315606D0 (en) Process for preparing non-hygroscopic azithromycin dihydrate
HUP0302199A3 (en) Retarding agents for preparing purified brine
AU2002247886A1 (en) Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists
HUP0204443A3 (en) Process for preparing fluoroformates
EP1338654A4 (en) METHOD FOR PRODUCING A NUCLEOSIDE COMPOUND
GB2411654B (en) Process for the preparation of metal acetylacetonates
HRP20000680B1 (en) Process for the preparation of fluconazole
AU2287902A (en) New process for the preparation diaryl-4-amino-piperidinyl compounds